@misc{indiciae3e017e1f371f,
  title = {Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potential},
  author = {Martinez, D. R. and Moreira, F. and Zweigart, M. R. and Gully, K. L. and De la Cruz, G. and Brown, A. and Adams, L. E. and Catanzaro, N. and Yount, B. and Baric, T. J. and Mallory, M. and Conrad, H. and May, S. R. and Dong, S. and Scobey, T. D. and Montgomery, S. and Perry, J. K. and Babusis, D. and Barrett, K. and Nguyen, A.-H. and Nguyen, A.-Q. and Kalla, R. and Bannister, R. and Bilello, J. and Feng, J. and Cihlar, T. and Baric, R. S. and Mackman, R. and Schaefer, A. and Sheahan, T. P.},
  year = {2023},
  doi = {10.1101/2023.06.27.546784},
  url = {https://www.biorxiv.org/content/10.1101/2023.06.27.546784v1},
  note = {Source identifier: 10.1101/2023.06.27.546784}
}